Founders & Advisors

Cornelia Weyand, M.D., Ph.D.

Cornelia Weyand, M.D., Ph.D.

Mayo Clinic

Senior Scientific Advisor

Cornelia Weyand is Professor of Medicine and Immunology at the Mayo Clinic, Alix School of Medicine and Professor of Medicine Emerita at Stanford University, School of Medicine. She is the Director of the Program in Immunity and Inflammation, dedicated to the translation of molecular immunology into the care of patients with inflammatory disease.

Her research has contributed to the understanding of how the human immune system ages and how this leads to tissue inflammation. Dr. Weyand and her team have defined successful and maladaptive immune aging and are developing therapeutic strategies to slow down the immune aging process. Together with her research team, she has examined immune malfunction in two disease states, rheumatoid arthritis and vasculitis of the large blood vessels. Her research has identified and characterized immune cells that mediate medium vessel vasculitis and has defined the molecular underpinnings of immuno-stromal interactions that cause arterial inflammation. By examining immune cells from affected patients, her group has defined mechanism of tissue invasion of inflammatory cells, arrest and survival signals that hold inflammatory cells in the tissue and the energy sources that allow inflammatory cells to fuel their pathogenic behaviors.

Previously, Dr. Weyand was the Chief of Immunology and Rheumatology in the Department of Medicine at Stanford University, School of Medicine. Dr. Weyand held the David C. Lowance Chair in Medicine at Emory University and was the Director of the Lowance Center for Human Immunology and Rheumatology.

Earlier in her career, she was the Barbara Woodward Lips Professor of Medicine and Immunology at Mayo Medical and Graduate School, and she also directed the Clinical Immunology and Immunotherapeutics Program at the Mayo Clinic. Dr. Weyand completed her Residency in Germany at Hannover Medical School and was a Fellow with the Institute of Immunology and Genetics at the German Cancer Research Center. She has also been a Fellow in the Department of Medicine at the University of Heidelberg.